Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario
A Campennì, L Giovanella, SA Pignata… - Nuclear Medicine …, 2015 - journals.lww.com
Objective Differentiated thyroid cancer is rare, but the incidence has been increasing in the
last few decades. Early treatment is based on surgery and thyroid remnant ablation (TRA) by …
last few decades. Early treatment is based on surgery and thyroid remnant ablation (TRA) by …
Effectiveness of reduced radioiodine activity for thyroid remnant ablation after total thyroidectomy in patients with low to intermediate risk differentiated thyroid …
A Todica, S Haidvogl, WP Fendler… - Nuklearmedizin …, 2017 - thieme-connect.com
Aim: To compare the success rates of radioiodine therapy (RIT) for thyroid remnant ablation
(TRA) after the administration of a high-standard activity (3700 MBq; 100 mCi) to a lower …
(TRA) after the administration of a high-standard activity (3700 MBq; 100 mCi) to a lower …
Comparison of therapeutic efficacy and clinical parameters between recombinant human thyroid stimulating hormone and thyroid hormone withdrawal in high-dose …
S Choi, CJ Na, J Kim, YH Han, HK Kim… - Nuclear Medicine and …, 2015 - Springer
Purpose High-dose radioiodine treatment (HD-RIT) after injection of recombinant human
thyroid stimulating hormone (rh-TSH) has become widely used. This study compared the …
thyroid stimulating hormone (rh-TSH) has become widely used. This study compared the …
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal …
A Campennì, E Amato, R Laudicella, A Alibrandi… - Endocrine, 2019 - Springer
Purpose In DTC patients, 131-radioiodine therapy has routinely been used for many years
for thyroid remnant ablation after thyroid surgery. To date, two different strategies can be …
for thyroid remnant ablation after thyroid surgery. To date, two different strategies can be …
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature
L Lamartina, C Durante, S Filetti… - The Journal of Clinical …, 2015 - academic.oup.com
Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …
Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation
F Vianello, R Mazzarotto, C Mian, O Lora, G Saladini… - Clinical Oncology, 2012 - Elsevier
AIM: Recombinant human thyroid-stimulating hormone (rhTSH) has been approved in
Europe as a preparation tool for radioiodine ablation of post-surgical thyroid remnants in …
Europe as a preparation tool for radioiodine ablation of post-surgical thyroid remnants in …
[HTML][HTML] The effectiveness of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal prior to radioiodine remnant ablation in thyroid …
We evaluated the efficacy of recombinant human thyroid-stimulating hormone (rhTSH)
versus thyroid hormone withdrawal (THW) prior to radioiodine remnant ablation (RRA) in …
versus thyroid hormone withdrawal (THW) prior to radioiodine remnant ablation (RRA) in …
Recombinant human TSH–assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone …
RM Tuttle, M Brokhin, G Omry… - Journal of Nuclear …, 2008 - Soc Nuclear Med
Recent studies have confirmed that radioactive iodine therapy after recombinant human
TSH (rhTSH) stimulation effectively ablates the normal thyroid remnant. However, no …
TSH (rhTSH) stimulation effectively ablates the normal thyroid remnant. However, no …
Radioiodine post-surgical remnant ablation in patients with differentiated thyroid cancer: news from the last 10 years.
E Molinaro, L Pieruzzi, D Viola - Journal of Endocrinological …, 2012 - europepmc.org
Due to the growing incidence of differentiated thyroid carcinoma (DTC) and in particular of
small papillary thyroid cancer observed in the last few decades, the indications, the activity …
small papillary thyroid cancer observed in the last few decades, the indications, the activity …
Comparison of efficacy of 2220 MBq versus 3700 MBq I-131 for ablation of thyroid remnant in patients with differentiated thyroid cancer.
Aim We evaluated the efficacy of two doses of I-131 (2220 MBq versus 3700 MBq) after
thyroid hormone withdrawal for thyroid remnant ablation postoperatively in patients with …
thyroid hormone withdrawal for thyroid remnant ablation postoperatively in patients with …